Business Today: Latest Business News, India economy News, Stock Markets, Sensex, Mutual Funds and Indian Tax
Loading...
Search

Total 123 results found. Search for [ corona vaccine covaxin ]

Results 1 to 21 of 123
BusinessToday.In
New Delhi, May 6, 2021
As more and more people get COVID-19 in the country, questions are being raised about whether we are inching closer to herd immunity. The exposure to the infection of SARS CoV- 2 is at an all-time high with the reproductive rate at a shocking 1.44% of the population, which means one infected patient is infecting one and a half people. Sero surveys across cities in India have shown a high exposure to infection but experts believe that it is not translating to herd immunity. Watch the video for more.Also Read: Supreme Court asks Centre to prepare for third wave of COVID-19


BusinessToday.In
May 3, 2021
Ministry says as of May 2, Centre has provided more 16.54 crore vaccine doses to states/UTs for free. Over 78 lakh doses are still available with states/UTs to be administered and over 56 lakh doses will be received in next three days


Shailendra Shukla
New Delhi, May 1, 2021
Reliance Retail becomes fourth Indian company to achieve $100 billion valuationReliance Retail has become the fourth Indian company to top $100 billion valuation  mark. The company sells everything from grocery to electronics, through its chain of retail stores spread across the country. Currently, unlisted shares of Reliance Retail are trading in the range of Rs 1,500 and Rs 1,550 apiece. At Rs 1,500 per share, the firm is valued at Rs 7.5 lakh crore, according to a report in The Econo...


BusinessToday.In
New Delhi, April 30, 2021
Delhi CM Arvind Kejriwal has appealed to the people in the capital belonging to the age group of 18-44 years to not queue up outside vaccination centres from May 1 as Delhi has not received vaccines as of now. He said in the next one-two days, around 3 lakh Covishield vaccines will be received and the drive for vaccinating people above 18 years will commence. Kejriwal added that the Delhi government will inform people as soon as the vaccines arrive and everyone in the capital will be vaccinated, but a little cooperation is needed. The third phase of the Covid-19 vaccination drive to inoculate people in the 18-44 age group will roll out across the country on May 1. However, Delhi and some other states have said that they would be unable to do so due to the shortage of vaccine doses. Watch the video for more.Also Read: How to manage mild COVID-19 at home? Centre issues tips


BusinessToday.In
April 29, 2021
The US State Department added that there are 14 direct daily flights between India and the US as well as other services that connect through Europe


BusinessToday.In
April 28, 2021
As of now, the total cases stand at 1,79,97,267. As many as 1,48,17,371 people have recovered. The death toll in India has risen to 2,01,187


PB Jayakumar
April 26, 2021
World Health Organisation (WHO)'s data on 'Landscape of candidate vaccines in clinical development' says a total of 91 vaccine candidates have reached the clinical development stage


PTI
April 26, 2021
In a statement issued on Sunday, the UP government said that in pursuance with the Centre's order, Chief Minister Yogi Adityanath is planning to take the vaccine across the state in an organised manner


BusinessToday.In
April 24, 2021
At these rates, Covaxin will be twice as costly as Covishield, which will be sold to state governments at Rs 400 per dose and to private hospitals at Rs 600 per dose in Phase 3 of vacccination drive


BusinessToday.In
New Delhi, April 22, 2021
Adar Poonawalla, CEO, Serum Institute of India, explains the impact of the Covishield vaccine on the double mutant strain present in India. In an exclusive conversation with India Today, Poonawalla said that the COVID vaccines were initially developed with an idea to reduce the death numbers, keep people away from getting hospitalised and lower the burden on doctors. He added that Covishield has displayed 90% efficacy against all coronavirus variants, keeping people away from the need for oxygen and ventilators. On the other hand, the healthcare sector is going through an acute shortage of beds, ventilators and oxygen in India. Watch the video for more details. Also Read: COVID-19: Pfizer to supply coronavirus vaccine at 'not-for-profit' rate to Centre


BusinessToday.In
New Delhi, April 22, 2021
Bharat Biotech's COVID-19 vaccine has shown an overall interim clinical efficacy of 78 per cent and 100 per cent efficacy against severe COVID-19 disease; Putting tremendous pressure on the nation's medical infrastructure, the latest surge in COVID-19 cases has driven up the demand for medical oxygen, a critical commodity in treating the respiratory ailment; At the current pace of vaccination against coronavirus, India would need another 8 years and 9 months to inoculate 70 per cent of its entire population, a threshold required to achieve herd immunity. Watch this and more news on News Blast. Read | COVID-19: Tips from psychologists to cope in these uncertain timesAlso Read | AUMs of Indian Mutual Fund industry decreases 0.5% m-o-m


BusinessToday.In
April 22, 2021
ICMR Director General Balram Bhargava said that merely 0.04 per cent of 17,37,178 individuals, who received a second dose of Covaxin were tested positive for the coronavirus


Rashi Bisaria
New Delhi, April 22, 2021
New COVID-19 mutant in Bengal, escapes antibodies' immunity Scientists have found a new lineage of the SARS-CoV-2 virus named 'B.1.618' in India, which is predominantly circulating in West Bengal. This is the second lineage to be identified from the country. The infection through this variant makes plasma therapy as redundant as an investigational treatment. 600% jump in oxygen demand from hospitals Putting tremendous pressure on the nation's medical infrastructure, the latest surge in ...


BusinessToday.In
New Delhi, April 21, 2021
India's indigenous COVID-19 vaccine Covaxin is effective against multiple variants, including the double mutant variant of SARS-CoV-2, the Indian Council of Medical Research (ICMR) said on Wednesday. The ICMR said the studies showed that Covaxin also neutralised the UK and Brazil variants of SARS-CoV-2, the coronavirus that causes COVID-19. The double mutant variant is expected to have fuelled the second wave of COVID-19 pandemic in India. Covaxin was developed in collaboration with the ICMR, the National Institute of Virology (NIV) and vaccine manufacturer Bharat Biotech. It was developed using a sample of coronavirus isolated by the NIV. Watch the video for more.Also Read: COVID-19 vaccination: India needs 8 yrs 9 months to achieve herd immunity


BusinessToday.In
New Delhi, April 21, 2021
Prime Minister Narendra Modi addressed the nation on Tuesday and spoke about the prevailing COVID-19 situation in the country. He said the situation in India was under control until some weeks ago, but the second wave of COVID has come like a storm. The Prime Minister said India is currently fighting a very tough battle against COVID-19 and urged people to follow COVID-appropriate behaviour. In his address to the nation, PM Modi thanked doctors, medical staff, paramedical staff, ambulance drivers, security forces and police for their services during the pandemic. He also added that India is fortunate to have a strong pharma sector that makes quality medicines speedily. Watch the video for more.Also Read: Bharat Biotech's Covaxin 78% effective; works against most COVID-19 variants


BusinessToday.In
New Delhi, April 21, 2021
Congress leader P Chidambaram on Tuesday slammed the government over its revised vaccine policy.  Chidambaram stated that the new vaccine policy is 'heartless' and 'lacks vision'; To support vaccination campaigns in India and across the globe, Bharat Biotech has ramped up the manufacturing capacity of its COVID-19 vaccine, Covaxin, to 700 million doses per annum, the vaccine maker said on Tuesday; Finance Minister Nirmala Sitharaman on Tuesday, April 20, said that there should be absolute trust between the industry and the government to support growth in the wake of the COVID-19 situation in the country. Watch this and more on News Blast.Also Read: 22 patients die in Nashik hospital after oxygen leak from tanker


Ashutosh Kumar
April 19, 2021
The government will make pre-payment to both Serum Institute of India and Bharat Biotech for the vaccine supply. \"This will serve as an incentive to the two vaccine suppliers,\" said a source


BusinessToday.In
April 19, 2021
States have been empowered to procure additional vaccine doses directly from the manufacturers, as well as open up vaccination to any category of people above the age of 18 years.


BusinessToday.In
April 16, 2021
People coming from Punjab, Delhi, Maharashtra, Gujarat, Karnataka, Rajasthan and Uttar Pradesh will have to show that they have tested negative for coronavirus in the preceding 72 hours while entering the state


BusinessToday.In
April 14, 2021
Coronavirus vaccination: After taking the first shot, the vaccine beneficiary will receive a message on his/her registered mobile number about the link to download the vaccination certificate


PAGES 1 OF 7  12345